Gallium-68 radiotracers for Alzheimer’s plaque imaging

Abstract

Alzheimer's disease (AD) is a brain disorder with aggravating symptoms of memory loss and dementia mainly in the elderly population. Imaging tools of β-amyloid (Aβ) plaques are necessary for clinical and neuropsychological characteristics in AD. This is in order to gain global understanding of the disease by the design and selection of effective drugs. Positron emission tomography (PET) is a notable tool for drug advancement because of its high sensitivity and capacity to produce quantitative and kinetic data.

Editorial Review 2015 – Nuclear Medicine, Diagnostic Imaging and Therapy

“…The final article of 2015 was on 'Gallium-68 radiotracers for Alzheimer's plaque imaging', by BarriosLopez et al [9]. The application of imaging tools towards the diagnosis of the brain disorder Alzheimer's disease (AD).…”